...
首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Influence of common genetic variation on blood lipid levels, cardiovascular risk, and coronary events in two British prospective cohort studies
【24h】

Influence of common genetic variation on blood lipid levels, cardiovascular risk, and coronary events in two British prospective cohort studies

机译:在两项英国前瞻性队列研究中,常见遗传变异对血脂水平,心血管风险和冠脉事件的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AimsThe aim of this study was to quantify the collective effect of common lipid-associated single nucleotide polymorphisms (SNPs) on blood lipid levels, cardiovascular risk, use of lipid-lowering medication, and risk of coronary heart disease (CHD) events.Methods and resultsAnalysis was performed in two prospective cohorts: Whitehall II (WHII; N = 5059) and the British Women's Heart and Health Study (BWHHS; N = 3414). For each participant, scores were calculated based on the cumulative effect of multiple genetic variants influencing total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Compared with the bottom quintile, individuals in the top quintile of the LDL-C genetic score distribution had higher LDL-C {mean difference of 0.85 [95% confidence interval, (CI) = 0.76-0.94] and 0.63 [95% CI = 0.50-0.76] mmol/l in WHII and BWHHS, respectively. They also tended to have greater odds of having 'high-risk' status (Framingham 10-year cardiovascular disease risk >20%) [WHII: odds ratio (OR) = 1.36 (0.93-1.98), BWHHS: OR = 1.49 (1.14-1.94)]; receiving lipid-lowering treatment [WHII: OR = 2.38 (1.57-3.59), BWHHS: OR = 2.24 (1.52-3.29)]; and CHD events [WHII: OR = 1.43 (1.02-2.00), BWHHS: OR = 1.31 (0.99-1.72)]. Similar associations were observed for the TC score in both studies. The TG score was associated with high-risk status and medication use in both studies. Neither HDL nor TG scores were associated with the risk of coronary events. The genetic scores did not improve discrimination over the Framingham risk score.ConclusionAt the population level, common SNPs associated with LDL-C and TC contribute to blood lipid variation, cardiovascular risk, use of lipid-lowering medications and coronary events. However, their effects are too small to discriminate future lipid-lowering medication requirements or coronary events. ? 2012 The Author.
机译:目的本研究旨在量化常见脂质相关单核苷酸多态性(SNP)对血脂水平,心血管疾病风险,使用降脂药物和冠心病(CHD)事件风险的集体影响。结果在两个前瞻性队列中进行了分析:Whitehall II(WHII; N = 5059)和英国女性心脏与健康研究(BWHHS; N = 3414)。对于每个参与者,根据影响总胆固醇(TC),低密度脂蛋白胆固醇(LDL-C),高密度脂蛋白胆固醇(HDL-C)和甘油三酸酯(TG)的多种遗传变异的累积效应来计算分数。与最低的五分位数相比,LDL-C遗传得分分布的最高五分位数的个体具有更高的LDL-C {平均差异为0.85 [95%置信区间,(CI)= 0.76-0.94]和0.63 [95%CI =在WHII和BWHHS中分别为0.50-0.76] mmol / l。他们也倾向于具有“高风险”状态的可能性更大(弗拉明汉10年心血管疾病风险> 20%)[WHII:优势比(OR)= 1.36(0.93-1.98),BWHHS:OR = 1.49(1.14) -1.94)];接受降脂治疗[WHII:OR = 2.38(1.57-3.59),BWHHS:OR = 2.24(1.52-3.29)];和CHD事件[WHII:OR = 1.43(1.02-2.00),BWHHS:OR = 1.31(0.99-1.72)]。在两项研究中,TC评分均观察到相似的关联。两项研究中,TG评分均与高危状态和药物使用相关。 HDL和TG评分均与冠心病发生风险无关。遗传评分并未改善对Framingham风险评分的歧视。结论在人群水平上,与LDL-C和TC相关的常见SNP会导致血脂变异,心血管疾病风险,使用降脂药物和冠心病。但是,它们的作用太小,无法区分未来的降脂药物需求或冠心病。 ? 2012作者。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号